- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- General
- Haemato-oncology
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Jonathan Sive is an expert haematologist based in London. He specialises in the diagnosis and management of blood cancers, with particular expertise in the treatment of myeloma and other related disorders such as MGUS and plasmacytomas. He is the Clinical Service Lead for the UCLH myeloma service - the largest in the UK, and has a specialist interest in POEMS Syndrome.He is also highly experienced in the investigation of abnormal blood counts and paraproteins.
After qualifying, he completed specialist training in haematology at University College London Hospital and carried out a PhD at Cambridge University, where he investigated the use of genomic technologies to study the mechanisms of leukaemia development. He currently practises as a consultant haematologist at University College London Hospital, where he also has a private practice
Dr Sive is committed to research which improves treatment outcomes for all patients. In this respect, he is actively engaged in a variety of clinical research projects and takes a leading role in the development of national guidelines.
He is the lead author of the new UK national guidelines for the diagnosis and initial treatment of myeloma. These are published by the British Society for Haematology and the UK Myeloma Forum, and provide the standard for practice throughout the UK. https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.17410
His work has been widely published in numerous peer-reviewed journals and book chapters. He is also a member of the British Society for Haematology (BSH) and the UK Myeloma Research Alliance, and is member of the executive committee of the UK Myeloma Forum.
A skilled clinician, Dr Sive combines his academic expertise in blood disorders with dedication to delivering an excellent standard of care to every patient. He is known for his clear and empathetic communication style and will explore all treatment options relevant to the patient’s circumstances in an honest and sensitive manner.
Areas of interest
Haematological malignancy; myeloma; MGUS; general haematology (including investigation and management of paraproteins, anaemia, high and low white cell counts, neutropenia, high and low platelet counts, iron deficiency)
Medical secretaries
- Siobhán Walsh
- Leaders in Oncology Care 95-97 Harley Street London W1G 6AF
- 020 7317 2631
- JonathanSivePA@theloc.com
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)